• Merck Awarded Australian CRISPR Nickase Patent americanpharmaceuticalreview
    August 16, 2018
    Merck announced the Australian Patent Office has allowed the company's patent application for the use of paired CRISPR nickases. Paired nickases represent a step in increasing safety by driving specificity through a highly flexible and efficient approach
PharmaSources Customer Service